# A Phase I Study of SIM0388 in Participants With Malignant Ascites.

> **NCT07007988** · PHASE1 · RECRUITING · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Malignant Ascites

## Interventions

- **DRUG:** SIM0388
- **DRUG:** SIM0388

## Key facts

- **NCT ID:** NCT07007988
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-24
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007988, "A Phase I Study of SIM0388 in Participants With Malignant Ascites.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07007988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*